These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1346069)

  • 1. Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range.
    Le Guern M; Levy JA
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):363-7. PubMed ID: 1346069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses.
    Walker CM; Thomson-Honnebier GA; Hsueh FC; Erickson AL; Pan LZ; Levy JA
    Cell Immunol; 1991 Oct; 137(2):420-8. PubMed ID: 1680028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates.
    Mosier DE; Gulizia RJ; MacIsaac PD; Torbett BE; Levy JA
    Science; 1993 Apr; 260(5108):689-92. PubMed ID: 8097595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Several CD4 domains can play a role in human immunodeficiency virus infection in cells.
    Poulin L; Evans LA; Tang SB; Barboza A; Legg H; Littman DR; Levy JA
    J Virol; 1991 Sep; 65(9):4893-901. PubMed ID: 1714523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells.
    De Maria A; Pantaleo G; Schnittman SM; Greenhouse JJ; Baseler M; Orenstein JM; Fauci AS
    J Immunol; 1991 Apr; 146(7):2220-6. PubMed ID: 1706390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination.
    Iwabu Y; Mizuta H; Kawase M; Kameoka M; Goto T; Ikuta K
    Microbes Infect; 2008 Apr; 10(5):504-13. PubMed ID: 18403230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.
    Wildum S; Schindler M; Münch J; Kirchhoff F
    J Virol; 2006 Aug; 80(16):8047-59. PubMed ID: 16873261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superinfection of human immunodeficiency virus type 1 (HIV-1) to cell clone persistently infected with defective virus induces production of highly cytopathogenic HIV-1.
    Iwabu Y; Goto T; Tsuji S; Warachit J; Li GM; Shoji S; Kameoka M; Ikuta K
    Microbes Infect; 2006 Jun; 8(7):1773-82. PubMed ID: 16815724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells.
    Barker E; Bossart KN; Locher CP; Patterson BK; Levy JA
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():2953-62. PubMed ID: 9000085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 (HIV-1) infection of herpesvirus saimiri-immortalized human CD4-positive T lymphoblastoid cells: evidence of enhanced HIV-1 replication and cytopathic effects caused by endogenous interferon-gamma.
    Saha K; Caruso M; Volsky DJ
    Virology; 1997 Apr; 231(1):1-9. PubMed ID: 9143296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level of surface CD4 prevents stable human immunodeficiency virus infection of T-cell transfectants.
    Marshall WL; Diamond DC; Kowalski MM; Finberg RW
    J Virol; 1992 Sep; 66(9):5492-9. PubMed ID: 1501285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral reactivation and pseudotype production in an in vitro superinfection system with two different strains of HIV-1.
    Fernández Larrosa PN; Ceballos A; Andreani G; Marquina S; Martínez Peralta L; Rabinovich RD
    Arch Virol; 2006 Apr; 151(4):651-62. PubMed ID: 16362643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of EBV-carrying B cell lines to infection by HIV-1: variability of production of progeny virus and expression of viral antigens.
    Tremblay M; Wainberg MA
    Cancer Lett; 1989 Nov; 48(2):95-103. PubMed ID: 2479462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential human immunodeficiency virus expression in CD4+ cloned lymphocytes: from viral latency to replication.
    Chapel A; Bensussan A; Vilmer E; Dormont D
    J Virol; 1992 Jun; 66(6):3966-70. PubMed ID: 1374814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma.
    Lo SC; Tsai S; Benish JR; Shih JW; Wear DJ; Wong DM
    Science; 1991 Mar; 251(4997):1074-6. PubMed ID: 1705362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication of HIV-1 in a wide variety of animal cells following phenotypic mixing with murine retroviruses.
    Canivet M; Hoffman AD; Hardy D; Sernatinger J; Levy JA
    Virology; 1990 Oct; 178(2):543-51. PubMed ID: 2171193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 pseudotype virus containing a Cocal virus genome and an HIV envelope: construction, assay and use.
    Gregory S; Collman R; James W; Gordon S; Gonzalez-Scarano F; Nathanson N
    J Virol Methods; 1993 Oct; 44(2-3):287-304. PubMed ID: 8263122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of human monoclonal antibody-producing B cell lines to infection by human immunodeficiency virus.
    Shepherd AJ; Boyd JE; Hogg CL; Aw D; James K
    Hum Antibodies Hybridomas; 1992 Oct; 3(4):168-76. PubMed ID: 1335786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.
    Bollinger RC; Quinn TC; Liu AY; Stanhope PE; Hammond SA; Viveen R; Clements ML; Siliciano RF
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1067-77. PubMed ID: 7906131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals.
    Maggi E; Annunziato F; Manetti R; Biagiotti R; Giudizi MG; Ravina A; Almerigogna F; Boiani N; Alderson M; Romagnani S
    Immunity; 1995 Aug; 3(2):251-5. PubMed ID: 7648397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.